Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Introduction: There is some controversy over the efficacy of statins for the prevention of contrastinduced nephropathy (CIN). There have also been reports on varying efficacies of different statins. Hence, in this study the efficacy of atorvastatin and rosuvastatin for the prevention of CIN was asse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cardiovasc Thorac Res
Main Authors: Firouzi, Ata, Kazem Moussavi, Ali, Mohebbi, Ahmad, Alemzadeh-Ansari, Mohammad Javad, Kiani, Reza, Sanati, Hamid Reza, Mohebbi, Bahram, Shakerian, Farshad, Zahedmehr, Ali, Ansari-Ramandi, Mohammad Mostafa, Oni Heris, Saeed, Ghaleshi, Bahar, Ghorbani, Fatemeh
Formato: Artigo
Idioma:Inglês
Publicado em: Tabriz University of Medical Sciences 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6203872/
https://ncbi.nlm.nih.gov/pubmed/30386535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/jcvtr.2018.24
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados